SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs & Pharmaceuticals informs about newspaper publication

18 Jan 2021 Evaluate

In continuation to letter dated 16th January, 2021, regarding approval of Un-audited Financial Results for Quarter & Nine months ended 31st December, 2020, Welcure Drugs & Pharmaceuticals has informed that it has enclosed the newspaper advertisement published, in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in ‘Financial Express (English) and Jansatta (Hindi)’ on 17th January, 2021.

The above information is a part of company’s filings submitted to BSE.


Welcure Drugs&Pharma Share Price

0.26 0.00 (0.00%)
05-Jun-2026 10:20 View Price Chart
Peers
Company Name CMP
Redington 242.90
Amrapali Industries 18.55
Adani Enterprises 3032.00
Rashi Peripheral 547.00
PDS 319.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×